Suchergebnisse - "Khan, Tariq Aziz"

PubPharm (4)

1

Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358) : a phase 1-2, open-label, multicohort trial

enthalten in: The Lancet. Oncology | 2024

von Oaknin, A. | Moore, K. | Meyer, T. | +17

2

Structural vaccinology, molecular simulation and immune simulation approaches to design multi-epitopes vaccine against John Cunningham virus

enthalten in: Microbial pathogenesis | 2024

von Suleman, M. | Khan, T. | Ejaz, H. | +8

3

Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck : The Phase 2 CheckMate 714 Randomized Clinical Trial

enthalten in: JAMA oncology | 2023

von Harrington, K. | Ferris, R. | Gillison, M. | +21

CommentIn: JAMA Oncol. 2023 Jun 1;9(6):789-790. - PMID 37022697

4

Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck : The Final Results of CheckMate 651

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Haddad, R. | Harrington, K. | Tahara, M. | +22

CommentIn: J Clin Oncol. 2023 Apr 20;41(12):2134-2137. - PMID 36877893

1
[1]